AUSTIN, Texas–(BUSINESS WIRE)–Natera, Inc. (Nasdaq: NTRA), a global leader in cell-free DNA and precision medicine, today announced that it has been named the Best in Class winner in the Cancer, Screening & Early Detection category at the Digital Health Hub Foundation Digital Health & AI Awards. The recognition highlights the impact of Natera’s Signatera™ molecular residual disease (MRD) test on cancer care.The winners were announced live at the 2026 HLTH Conference in Las Vegas. This

Subscribe to Our Newsletter

We keep your data private and share your data only with third parties that make this service possible. See our Privacy Policy for more information.